An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
作者信息
Wang Jin, Zou Heng, Corpe Christopher
机构信息
Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Shanghai, China.
Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Shanghai, China.
出版信息
J Infect. 2022 Jan;84(1):e21-e22. doi: 10.1016/j.jinf.2021.10.020. Epub 2021 Oct 30.
Abstract
摘要
相似文献
1
An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.在中国观察到血管紧张素转换酶2基因多态性与COVID-19严重程度之间的关联。
J Infect. 2022 Jan;84(1):e21-e22. doi: 10.1016/j.jinf.2021.10.020. Epub 2021 Oct 30.
2
Shining More Light on RAS Inhibition during the COVID-19 Pandemic.在新冠疫情期间，进一步揭示RAS抑制作用
Clin J Am Soc Nephrol. 2021 Jul;16(7):1002-1004. doi: 10.2215/CJN.06000521. Epub 2021 Jul 12.
3
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.假说：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能会增加 COVID-19 重症风险。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa041.
4
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂改善了重症新型冠状病毒肺炎合并高血压患者的预后。
Sci China Life Sci. 2021 May;64(5):836-839. doi: 10.1007/s11427-020-1813-0. Epub 2020 Sep 21.
5
Angiotensin-Converting Enzyme 2 Genetic Variants Are Associated With Coronavirus Disease 2019.血管紧张素转换酶2基因变异与2019冠状病毒病相关。
J Infect Dis. 2021 Dec 15;224(12):2181-2183. doi: 10.1093/infdis/jiab531.
6
COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?新型冠状病毒肺炎与高血压合并症：血管紧张素转换酶2是罪魁祸首吗？
Prehosp Disaster Med. 2020 Dec;35(6):700-701. doi: 10.1017/S1049023X20001090. Epub 2020 Aug 25.
7
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用：最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.
8
Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection.血管紧张素转化酶 2 阻滞剂对 SARS-CoV-2 感染中神经炎症的潜在影响。
Curr Drug Targets. 2022;23(4):364-372. doi: 10.2174/1389450122666211103165837.
9
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.血管紧张素转换酶抑制剂/血管紧张素II受体阻滞剂治疗及血流动力学因素与心血管疾病患者心脏中血管紧张素转换酶2的mRNA表达增加有关。
Eur J Heart Fail. 2020 Dec;22(12):2248-2257. doi: 10.1002/ejhf.2020. Epub 2020 Oct 20.
10
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.血管紧张素 II 受体阻滞剂和 ACE（血管紧张素转换酶）抑制剂对 COVID-19 合并高血压患者病毒感染、炎症状态和临床结局的影响：一项单中心回顾性研究。
Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29.
引用本文的文献
1
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.遗传因素预测 COVID-19 和 MAFLD 共病病程：综合分析。
Viruses. 2023 Aug 12;15(8):1724. doi: 10.3390/v15081724.
2
Association between single nucleotide polymorphism of human angiotensin-converting enzyme 2 gene locus and clinical severity of COVID-19.人类血管紧张素转换酶2基因位点单核苷酸多态性与新型冠状病毒肺炎临床严重程度的关联
Egypt J Med Hum Genet. 2022;23(1):125. doi: 10.1186/s43042-022-00331-8. Epub 2022 Aug 23.
3
Angiotensin-Converting Enzyme 2 SNPs as Common Genetic Loci and Optimal Early Identification Genetic Markers for COVID-19.血管紧张素转换酶2单核苷酸多态性作为2019冠状病毒病的常见遗传位点和最佳早期识别遗传标志物
Pathogens. 2022 Aug 22;11(8):947. doi: 10.3390/pathogens11080947.
4
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity.系统评价和荟萃分析人类遗传变异对 COVID-19 易感性和严重程度的影响。
Gene. 2022 Nov 30;844:146790. doi: 10.1016/j.gene.2022.146790. Epub 2022 Aug 17.
5
The association of , , , and polymorphisms with COVID-19 severity: A systematic review and meta-analysis.[基因名称1]、[基因名称2]、[基因名称3]、[基因名称4]和[基因名称5]多态性与新冠肺炎严重程度的关联：一项系统综述和荟萃分析。
EXCLI J. 2022 Jun 20;21:818-839. doi: 10.17179/excli2022-4976. eCollection 2022.
本文引用的文献
1
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.血管紧张素转换酶I/D多态性与新型冠状病毒肺炎的流行病学研究结果：欧洲大流行爆发一年后
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.002. Epub 2021 Jun 16.
2
SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.SARS-CoV-2 感染易感性受 ACE2 基因多态性影响：来自德黑兰心脏代谢遗传研究的见解。
Sci Rep. 2021 Jan 15;11(1):1529. doi: 10.1038/s41598-020-80325-x.
3
SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.SARS-CoV-2 受体 ACE2 基因与高血压和 COVID-19 严重程度相关：与性别、肥胖和吸烟的相互作用。
Am J Hypertens. 2021 Apr 20;34(4):367-376. doi: 10.1093/ajh/hpaa223.
4
Comprehensive in silico identification of impacts of SNPs on COVID-19 susceptibility in different populations.通过计算机模拟全面识别单核苷酸多态性对不同人群新冠病毒易感性的影响。
Gene Rep. 2021 Mar;22:100979. doi: 10.1016/j.genrep.2020.100979. Epub 2020 Dec 4.
5
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.血管紧张素转换酶基因型与 COVID-19 死亡率：一项生态学研究。
J Infect. 2020 Dec;81(6):961-965. doi: 10.1016/j.jinf.2020.11.012. Epub 2020 Nov 14.
6
Genetic Association of rs2285666 Polymorphism With COVID-19 Spatial Distribution in India.印度rs2285666多态性与COVID-19空间分布的遗传关联。
Front Genet. 2020 Sep 25;11:564741. doi: 10.3389/fgene.2020.564741. eCollection 2020.
7
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.血管紧张素转换酶（ACE，ACE2）基因变异与 COVID-19 结局。
Gene. 2020 Dec 15;762:145102. doi: 10.1016/j.gene.2020.145102. Epub 2020 Aug 31.
8
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响：综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
9
Association of ACE I/D Polymorphism with Risk of Diabetes in Cardiovascular Disease Patients.血管紧张素转换酶I/D多态性与心血管疾病患者患糖尿病风险的关联
Exp Clin Endocrinol Diabetes. 2020 Feb;128(2):82-88. doi: 10.1055/a-0824-6515. Epub 2019 Jan 14.
10
ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus.维吾尔族 2 型糖尿病患者心血管风险相关的 ACE2 多态性。
Cardiovasc Diabetol. 2018 Sep 18;17(1):127. doi: 10.1186/s12933-018-0771-3.
Zotero 插件